US 12,239,668 B2
Pharmaceutical composition comprising periodontal tissue-derived pluripotent stem cells for prevention or treatment of male infertility
Gyu Jin Rho, Jinju si (KR); Kyung Min Kim, Seoul (KR); Si Jung Jang, Jinji si (KR); Sung Lim Lee, Jinju si (KR); and Bong Wook Park, Jinju si (KR)
Assigned to Industry-Academic Cooperation Foundation Gyeongsang National University, (KR); and Stemcentric Co., Ltd., (KR)
Appl. No. 17/609,460
Filed by INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY, Jinju-si (KR); and STEMCENTRIC CO., LTD., Anyang-si (KR)
PCT Filed May 8, 2020, PCT No. PCT/KR2020/006091
§ 371(c)(1), (2) Date Nov. 8, 2021,
PCT Pub. No. WO2020/226451, PCT Pub. Date Nov. 12, 2020.
Claims priority of application No. 10-2019-0053424 (KR), filed on May 8, 2019.
Prior Publication US 2022/0226385 A1, Jul. 21, 2022
Int. Cl. A61K 35/12 (2015.01); A61K 35/28 (2015.01); A61K 35/32 (2015.01); A61P 5/24 (2006.01)
CPC A61K 35/28 (2013.01) [A61K 35/32 (2013.01); A61P 5/24 (2018.01)] 6 Claims
OG exemplary drawing
 
1. A method for treating male infertility in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising periodontal tissue-derived mesenchymal stem cells.